This Article Full Text Full Text (PDF) All Versions of this Article: 37/7/1749    most recent 01.STR.0000226980.95389.0bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Price, C. J.S. Articles by Warburton, E. A. Search for Related Content PubMed PubMed Citation Articles by Price, C. J.S. Articles by Warburton, E. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Pathophysiology Imaging Acute Cerebral Infarction PET and SPECT Pathology of Stroke Neuroprotectors

(Stroke. 2006;37:1749.)
© 2006 American Heart Association, Inc.

Original Contributions

Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic Stroke

Christopher J.S. Price, MRCP; Dechao Wang, PhD; David K. Menon, PhD; Joe V. Guadagno, MRCP; Marcel Cleij, PhD; Tim Fryer, PhD; Franklin Aigbirhio, PhD; Jean-Claude Baron, MD Elizabeth A. Warburton, DM

From the Department of Medicine, University of Cambridge, Addenbrookes Hospital, Cambridge, UK (C.J.S.P.); Wolfson Brain Imaging Centre, University of Cambridge, Addenbrookes Hospital, Cambridge, UK (C.J.S.P., D.W., D.K.M., J.V.G., M.C., T.F., F.A., J.C.B.); Anesthesia Section, Department of Medicine, University of Cambridge, Addenbrookes Hospital, Cambridge, UK (D.K.M.); Department of Neurology, University of Cambridge, Addenbrookes Hospital, Cambridge, UK (C.J.S.P., J.V.G., J.C.B.); and Department of Clinical Neurosciences, Cambridge University Teaching Hospitals Trust, Cambridge, UK (E.A.W.).

Correspondence to C.J.S. Price, Department of Medicine, University of Cambridge, Box 83, R3 Neuroscience, Addenbrookes Hospital, Cambridge, UK. E-mail cp252{at}medschl.cam.ac.uk

Background and Purpose— Microglial activation is an important component of the neuroinflammatory response to ischemic stroke. Experimental studies have outlined such patterns temporally and spatially. In vivo studies in stroke patients have relied on positron emission tomography and (R)-PK11195, a ligand that binds peripheral benzodiazepine binding sites. In this study we sought to establish temporal and spatial patterns of microglial activation in ischemic stroke with particular emphasis on a defined peri-infarct zone.

Methods— Using this technique, we studied carotid territory ischemic stroke patients in 3 time windows up to 30 days after ictus. Controls were studied in a single session. [¹¹C](R)-PK11195 injection was followed by 3-dimensional acquisition over 60 minutes. Cerebral blood volume (CBV) was measured afterward with the use of standard C¹⁵O paradigms. Analysis employed the reference tissue model in which ipsilateral cerebellum was used to generate parametric binding potential maps corrected for CBV. Data were coregistered to T1-based MRI. Using control data to identify 99% confidence limits, a region of interest analysis was applied to identify significant binding in core infarction, contralateral hemisphere, and within a defined peri-infarct zone.

Results— Four patients (mean age, 66 years) were imaged across 9 sessions. Four age-matched controls were studied. Within this model, ipsilateral cerebellum was validated as a reference tissue. With the use of control-derived confidence limits and correction for CBV, significant binding potential rises were identified beyond 72 hours and extending to 30 days in core infarction, contralateral hemisphere, and peri-infarct zone.

Conclusions— In ischemic stroke patients, minimal activation of microglia is seen before 72 hours. Beyond this, binding potential rises in core infarction, peri-infarct zone, and contralateral hemisphere to 30 days. This may represent a therapeutic opportunity that extends beyond time windows traditionally reserved for neuroprotection.

Key Words: inflammation • microglia • positron emission tomography • tomograpy, emission computed

This article has been cited by other articles:

				Y. Cui, T. Takashima, M. Takashima-Hirano, Y. Wada, M. Shukuri, Y. Tamura, H. Doi, H. Onoe, Y. Kataoka, and Y. Watanabe 11C-PK11195 PET for the In Vivo Evaluation of Neuroinflammation in the Rat Brain After Cortical Spreading Depression J. Nucl. Med., November 1, 2009; 50(11): 1904 - 1911. [Abstract] [Full Text] [PDF]

				I. Kane, T. Carpenter, F. Chappell, C. Rivers, P. Armitage, P. Sandercock, and J. Wardlaw Comparison of 10 Different Magnetic Resonance Perfusion Imaging Processing Methods in Acute Ischemic Stroke: Effect on Lesion Size, Proportion of Patients With Diffusion/Perfusion Mismatch, Clinical Scores, and Radiologic Outcomes Stroke, December 1, 2007; 38(12): 3158 - 3164. [Abstract] [Full Text] [PDF]

				A. Saleh, M. Schroeter, A. Ringelstein, H.-P. Hartung, M. Siebler, U. Modder, and S. Jander Iron Oxide Particle-Enhanced MRI Suggests Variability of Brain Inflammation at Early Stages After Ischemic Stroke Stroke, October 1, 2007; 38(10): 2733 - 2737. [Abstract] [Full Text] [PDF]

				H. Boutin, F. Chauveau, C. Thominiaux, M.-C. Gregoire, M. L. James, R. Trebossen, P. Hantraye, F. Dolle, B. Tavitian, and M. Kassiou 11C-DPA-713: A Novel Peripheral Benzodiazepine Receptor PET Ligand for In Vivo Imaging of Neuroinflammation J. Nucl. Med., April 1, 2007; 48(4): 573 - 581. [Abstract] [Full Text] [PDF]

				N. Nighoghossian, M. Wiart, S. Cakmak, Y. Berthezene, L. Derex, T.-H. Cho, C. Nemoz, F. Chapuis, G.-L. Tisserand, J.-B. Pialat, et al. Inflammatory Response After Ischemic Stroke: A USPIO-Enhanced MRI Study in Patients Stroke, February 1, 2007; 38(2): 303 - 307. [Abstract] [Full Text] [PDF]

				W.-D. Heiss and A. G. Sorensen Advances in Imaging 2006 Stroke, February 1, 2007; 38(2): 238 - 240. [Full Text] [PDF]